$85.27
0.58% day before yesterday
NYSE, Nov 26, 10:00 pm CET
ISIN
US83444M1018
Symbol
SOLV

Solventum Stock price

$85.27
+13.29 18.46% 1M
+14.46 20.42% 6M
+19.21 29.08% YTD
+13.78 19.28% 1Y
+5.27 6.59% 3Y
+5.27 6.59% 5Y
+5.27 6.59% 10Y
+5.27 6.59% 20Y
NYSE, Closing price Wed, Nov 26 2025
-0.50 0.58%
ISIN
US83444M1018
Symbol
SOLV
Index

New AI Insights on Solventum Insights AI Insights on Solventum

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$14.8b
Enterprise Value
$18.3b
Net debt
$3.5b
Cash
$1.6b
Shares outstanding
173.4m
Valuation (TTM | estimate)
P/E
9.8 | 14.1
P/S
1.8 | 1.8
EV/Sales
2.2 | 2.2
EV/FCF
365.7
P/B
3.0
Financial Health
Equity Ratio
20.5%
Return on Equity
16.2%
ROCE
6.4%
ROIC
6.4%
Debt/Equity
1.0
Financials (TTM | estimate)
Revenue
$8.4b | $8.4b
EBITDA
$1.2b | $2.1b
EBIT
$709.0m | $1.7b
Net Income
$1.5b | $1.1b
Free Cash Flow
$50.0m
Growth (TTM | estimate)
Revenue
2.3% | 2.2%
EBITDA
-33.5% | 27.3%
EBIT
-45.7% | 58.9%
Net Income
111.7% | 119.6%
Free Cash Flow
-95.7%
Margin (TTM | estimate)
Gross
54.2%
EBITDA
14.7% | 25.0%
EBIT
8.4%
Net
18.1% | 12.5%
Free Cash Flow
0.6%
More
EPS
$8.7
FCF per Share
$0.3
Short interest
2.9%
Employees
-
Rev per Employee
-
Show more

Is Solventum a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,070 stocks worldwide.

Solventum Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a Solventum forecast:

10x Buy
48%
10x Hold
48%
1x Sell
5%

Analyst Opinions

21 Analysts have issued a Solventum forecast:

Buy
48%
Hold
48%
Sell
5%

Financial data from Solventum

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
8,402 8,402
2% 2%
100%
- Direct Costs 3,850 3,850
7% 7%
46%
4,552 4,552
2% 2%
54%
- Selling and Administrative Expenses 3,091 3,091
21% 21%
37%
- Research and Development Expense 752 752
2% 2%
9%
1,231 1,231
33% 33%
15%
- Depreciation and Amortization 522 522
4% 4%
6%
EBIT (Operating Income) EBIT 709 709
46% 46%
8%
Net Profit 1,524 1,524
112% 112%
18%

In millions USD.

Don't miss a Thing! We will send you all news about Solventum directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Solventum Stock News

Neutral
PRNewsWire
2 days ago
ST. PAUL, Minn. , Nov. 25, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in a fireside chat at the Piper Sandler Healthcare Conference on Tuesday, Dec. 2, 2025, beginning at approximately 10:00 a.m.
Neutral
Seeking Alpha
6 days ago
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Neutral
PRNewsWire
7 days ago
ST. PAUL, Minn. , Nov. 20, 2025 /PRNewswire/ -- Solventum  (NYSE: SOLV) announced today its Board of Directors has approved a share repurchase program, which authorizes the Company to purchase up to $1 billion of the Company's outstanding common stock.
More Solventum News

Company Profile

Solventum Corp. operates as a health care company. The company was founded on January 24, 2023 and is headquartered in Maplewood, MN.

Head office United States
CEO Bryan Hanson
Website www.solventum.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today